![Steven Y. Hua](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steven Y. Hua
Geen lopende functies
Profiel
Steven Y.
Hua worked as a Biostatistics Director at Celgene Corp.
and Pfizer Inc. He also served as the Vice President-Biometrics at Kezar Life Sciences, Inc. Dr. Hua holds a graduate degree from The University of Chicago and a doctorate degree from The University of Texas at Arlington.
Eerdere bekende functies van Steven Y. Hua
Bedrijven | Functie | Einde |
---|---|---|
KEZAR LIFE SCIENCES, INC. | Corporate Officer/Principal | 01-05-2023 |
CELGENE | Corporate Officer/Principal | - |
PFIZER, INC. | Corporate Officer/Principal | - |
Opleiding van Steven Y. Hua
The University of Texas at Arlington | Doctorate Degree |
The University of Chicago | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
KEZAR LIFE SCIENCES, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Celgene Corp.
![]() Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |